Skip to contentZELDIS JEROME B — PTC THERAPEUTICS, INC. insider: 121 transactions · InsiderLensZELDIS JEROME B
- Director at IR BIOSCIENCES HOLDINGS INC · on record since Feb 17, 2009
- Director at DOR BIOPHARMA INC · on record since Jun 24, 2011
- Director at HEPALIFE TECHNOLOGIES INC · on record since May 21, 2012
- Director at PTC THERAPEUTICS, INC. · on record since Jun 19, 2013
- See Remarks at QUIKBYTE SOFTWARE INC · on record since Nov 15, 2016
- Director at Streamex Corp. · on record since Jul 20, 2015
- Director at Bigstring CORP · on record since May 31, 2016
- Director at AIT Therapeutics, Inc. · on record since Apr 19, 2017
- Director at NEXGEL, INC. · on record since Mar 12, 2021
- Executive VP of Research & Dev at NexImmune, Inc. · on record since Feb 11, 2021
Insider trading activity of ZELDIS JEROME B
- Transactions on record
- 121
- since Feb 17, 2009
- Open-market buys
- 19
- $553.1K
- Open-market sells
- 7
- $2M
- Companies traded
- 9
- last filing Jan 6, 2026
Figures computed from official regulatory filings — methodology.
Companies where ZELDIS JEROME B has traded
- PTC THERAPEUTICS, INC.32 tx · $4.7M · Jan 6, 2026
- NEXGEL, INC.12 tx · $106.7K · Jun 27, 2025
- DOR BIOPHARMA INC27 tx · $64.9K · Jun 20, 2025
- NexImmune, Inc.3 tx · $100K · Apr 7, 2022
- Streamex Corp.12 tx · $164.3K · Jul 15, 2020
- QUIKBYTE SOFTWARE INC4 tx · $51.5K · Nov 27, 2018
- Bigstring CORP2 tx · Nov 21, 2017
- HEPALIFE TECHNOLOGIES INC26 tx · $440K · Jul 3, 2017
- IR BIOSCIENCES HOLDINGS INC3 tx · Aug 21, 2009
Track record of ZELDIS JEROME B
Statistical track record
Free- Open-market buys
- 20
- Last buy
- Nov 20, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of ZELDIS JEROME B
Co-insiders of ZELDIS JEROME B
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
1420525 ALBERTA LTD.HEPALIFE TECHNOLOGIES INC
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jan 6, 2026 | Award | 4,000 | 0.00 USD | $0 | SEC |
| Jan 6, 2026 | AwardD | 3,475 | 0.00 USD | $0 | SEC |
| Jun 27, 2025 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | AwardD | 17,647 | 0.00 USD | $0 | SEC |
| Jan 7, 2025 | Award | 4,000 | 0.00 USD | $0 | SEC |
| Jan 7, 2025 | AwardD | 8,800 | 0.00 USD | $0 | SEC |
| Dec 13, 2024 | AwardD | 8,646 | 0.00 USD | $0 | SEC |
| Dec 4, 2024 | Exercise | 12,000 | 51.00 USD | $612K | SEC |
| Dec 4, 2024 | Exercise | 12,000 | 30.86 USD | $370.3K | SEC |
| Dec 4, 2024 | Sell | -3,667 | 52.39 USD | $192.1K | SEC |
| Dec 4, 2024 | Sell | -3,187 | 52.42 USD | $167.1K | SEC |
| Dec 4, 2024 | Sell | -5,699 | 50.52 USD | $287.9K | SEC |
| Dec 4, 2024 | ExerciseD | -12,000 | 0.00 USD | $0 | SEC |
| Dec 4, 2024 | Sell | -8,813 | 51.44 USD | $453.3K | SEC |
| Dec 4, 2024 | ExerciseD | -12,000 | 0.00 USD | $0 | SEC |
| Dec 4, 2024 | Sell | -2,634 | 51.43 USD | $135.5K | SEC |
| Nov 22, 2024 | AwardD | 1,818 | 0.00 USD | $0 | SEC |
| Nov 22, 2024 | Buy | 3,636 | 2.75 USD | $10K | SEC |
| Sep 17, 2024 | AwardD | 25,000 | 0.00 USD | $0 | SEC |
| Aug 27, 2024 | AwardD | 5,000 | 0.00 USD | $0 | SEC |
| Aug 27, 2024 | Buy | 10,000 | 2.50 USD | $25K | SEC |
| May 24, 2024 | Exercise | 20,000 | 26.42 USD | $528.4K | SEC |
| May 24, 2024 | ExerciseD | -20,000 | 0.00 USD | $0 | SEC |
| May 24, 2024 | Sell | -20,000 | 38.24 USD | $764.8K | SEC |
| Feb 16, 2024 | AwardD | 10,000 | 0.00 USD | $0 | SEC |